News

The company claims that OmniExpress designed as a 12-sample Beadchip, allows interrogation of over 700,000 variants per sample totaling more than eight million available data points on a

In clinical trials, treatment with Fanapt resulted in improvement in symptoms of schizophrenia compared to patients on placebo, as demonstrated on two major scales for measuring the positive

As per the collaboration, the current scientific knowledge on Ipsogen’s MapQuant Dx Grade Genomic, HER2 and HR tests, will be increased to new data established from a large

The Phase 2a study has demonstrated proof-of-concept for DR Cysteamine, which is Raptor’s proprietary, delayed-release, enteric-coated microbead formulation of immediate release cysteamine bitartrate contained in a gelatin capsule.

The company said that the final Prelude device replaces the prototype device used in earlier clinical trials and will be tested in the near-term in a study using

The company claims that the new test is based on DNA methylation of the Septin9 gene, a biomarker associated with colorectal cancer that was identified by Epigenomics, a

The company claims that PureGraft is able to prepare both small and large volumes of fat grafting tissue, ranging from 50ml to 250ml. Puregraft maintains sterility while optimizing

Traficet-EN (CCX282-B), a specific CCR9 antagonist with the potential to offer a new approach for the treatment of inflammatory bowel diseases, including crohn’s disease. Reportedly, the option also

The company said that the Sentinel System, once operational, is expected to bolster the FDA’s efforts in monitoring product safety. Sentinel will provide FDA with the ability to